TyMe Screening — TyMe Institute

About

About TyMe Screening

At TyMe, we're transforming the way cancer is detected — early, accurately, and proactively. Our advanced screening services use a powerful blend of blood-based biomarkers, AI-assisted imaging, genomic insights, and immune profiling to uncover risks before symptoms emerge.

We're on a mission to detect cancer at its earliest and most treatable stages, using personalized screening strategies rooted in precision diagnostics and continuous monitoring.

TyMe Screening — advanced cancer detection

TyMe Cancer Screening is ideal for

Individuals with a family history of cancer
People who value proactive health management
Anyone seeking peace of mind through modern, preventive care

What We Screen

Our Screening Services

Whole-Body MRI

TyMe Whole-Body MRI combines advanced imaging technology with a precision prevention philosophy to provide a comprehensive view of your health in a single examination.

Performed in approximately 60 to 70 minutes, this radiation-free, non-invasive scan evaluates major organs and body systems through a comprehensive head-to-toe imaging approach using dedicated screening-focused MRI protocols. The goal is not simply to generate images, but to provide meaningful health insights that can support more informed decisions about prevention, wellness, and long-term health planning.

Precision Screening Laboratory Panel

Precision Screening Laboratory Panel is an advanced, physician-designed evaluation developed to support personalized cancer prevention and long-term wellness optimization.

Rather than offering a single standardized laboratory panel, TyMe provides multiple precision laboratory package options designed around different wellness goals, prevention priorities, and personalized health strategies.

Depending on the selected program, evaluations may include advanced biomarkers related to cardiovascular wellness, metabolic function, hormonal balance, inflammatory activity, nutritional status, digestive wellness, environmental exposure insights, recovery physiology, longevity-focused assessment, and broader preventive health patterns.

Selected biomarkers may also be periodically re-evaluated over time within certain TyMe programs to support longitudinal wellness monitoring and personalized health optimization planning.

Whole Genome Sequencing & Cancer Genomics Comprehensive Panel

Whole Genome Sequencing (WGS) & Cancer Genomics Comprehensive Panel

Whole Genome Sequencing is an advanced genomic analysis designed to evaluate an individual's DNA at a comprehensive level. As part of TyMe's precision prevention model, WGS may provide personalized genomic insights related to inherited biological patterns, selected health predispositions, and long-term prevention planning. The analysis is designed to support a more individualized understanding of health through advanced genomic evaluation and personalized biologic insight generation.

The Cancer Genomics Comprehensive Panel is a hereditary cancer-focused genetic evaluation that analyzes selected genes associated with inherited cancer risk patterns. This panel includes genes related to multiple hereditary cancer syndromes involving breast, ovarian, colorectal, pancreatic, prostate, endocrine, renal, skin, hematologic, and other cancer-associated conditions.

The goal is not to diagnose cancer, but to help identify inherited genetic information that may support personalized cancer prevention, screening decisions, and long-term risk-aware health planning.

Multi-Cancer Early Detection (MCED) Test

The Multi-Cancer Early Detection Test is an advanced blood test designed to identify cancer-associated signals that may be present in the bloodstream before symptoms develop.

Using sophisticated genomic and artificial intelligence technologies, the test analyzes patterns of cell-free DNA to evaluate whether a cancer signal may be present and, when detected, may help predict the tissue or organ system most likely associated with that signal.

Unlike traditional screening tests that focus on a single cancer type, this test is designed to evaluate signals associated with more than 50 types of cancer through a single blood draw.

This test is intended to complement—not replace—recommended cancer screening tests and guideline-based screening programs.

Hair Analysis

Hair Analysis is an advanced hair-based element and toxic exposure assessment designed to provide additional insight into long-term mineral balance, nutritional patterns, and selected environmental exposure trends.

Unlike blood testing, which primarily reflects short-term physiologic activity, hair analysis may help evaluate longer-term patterns related to essential minerals, heavy metals, and broader environmental influences.

The evaluation is designed to support more personalized wellness optimization, environmental exposure awareness, nutritional insight generation, and broader preventive health understanding.

InBody Body Composition Assessment

The InBody assessment is an advanced body composition analysis designed to provide a deeper understanding of body composition, muscle distribution, body fat, hydration status, and metabolic health beyond traditional weight or BMI measurements.

Using professional-grade bioelectrical impedance technology, the assessment evaluates key body composition metrics, providing detailed insights into skeletal muscle mass, body fat percentage, visceral fat, body water balance, and segmental body composition. The results help support more personalized nutrition, fitness, recovery, and wellness planning.

Differentiators

What Sets TyMe Apart

Advanced Precision Insights

Integrating AI, advanced imaging, genomics, and biomarkers.

Tailored Screening

Personalized based on your age, history, immune profile, and risk markers.

Proactive Strategy

Designed for wellness-seekers, not just patients.

Ongoing Monitoring

Longitudinal tracking for continuous insights, not just one-time snapshots.

Frequently Asked Questions

Everything you need to know about TyMe Screening.

TyMe Screening is a personalized cancer risk and early-detection program designed to look beyond routine annual care. It uses a more advanced approach that may include blood-based biomarkers, medical imaging, genomic insights, immune profiling, and individualized risk assessment to help identify concerns earlier and guide what kind of monitoring makes sense for you.

Primary care is essential, but most primary care visits are built around general health maintenance, acute issues, and standard guideline-based screening. TyMe is more focused and cancer-specific. We serve as a specialized partner focused on cancer risk, precision screening, and prevention, while your primary care doctor continues to manage your broader health needs.

TyMe Screening may be appropriate for people with a family history of cancer, those who want a more proactive and data-driven approach to health, and anyone seeking a more personalized view of their cancer risk rather than relying only on standard age-based screening.

No. TyMe Screening is not a standalone diagnosis. Its purpose is to assess risk, identify concerning signals, and determine whether you may need closer surveillance, additional testing, or referral for further evaluation.

That depends on your risk profile and what your baseline findings show. TyMe's model emphasizes continuous or longitudinal monitoring, which means we look at your health over time rather than relying only on a one-time snapshot.

If a potentially important or unexpected finding is identified, the results will be reviewed and discussed as part of the expert-guided evaluation process. Depending on the nature of the finding, individuals may be advised to follow up with their primary care physician or an appropriate medical specialist for further clinical evaluation, diagnostic workup, monitoring, or guideline-based management as appropriate.

No. In fact, TyMe is designed to be proactive. The goal is to identify risk and detect meaningful change before symptoms appear, not wait until disease becomes obvious.

Get ahead of disease & stay in control

With TyMe, you gain a decisive advantage in your health journey — anticipating risk before illness begins.

This is not just screening. It's a smarter way to live well.

Join waitlist